News

According to a new study, an experimental immunotherapy can temporarily reprogram patients’ immune cells to attack a specific target.

Self-spreading vaccines for animals intended to limit the spread of animal diseases or disease spillover to humans are being researched in Europe and the US.

An additional “booster” dose of Moderna or Pfizer mRNA-based vaccine is needed to provide immunity against the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, according to a new study.

According to a new study, a cancer immunotherapy drug currently approved by the U.S. Food and Drug Administration to treat several forms of cancer is also effective for treating aggressive forms of uterine cancer.

Researchers have developed a color-coded test that quickly signals whether newly developed nanoparticles deliver their cargo into target cells.

Researchers at Gladstone Institutes have fine-tuned an additional system for more efficient gene editing, using molecules called retrons.

Researchers have developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to endothelial cells.

Researchers have proven that COVID-19 vaccines can be kept ultra-cool for an extended period, providing a resource for safe delivery to remote locations.

A preclinical gene therapy addressing the primary cellular deficit of limb-girdle muscular dystrophy has been developed.

New research has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants simultaneously.